Uterine cancer statistics and tends: Victorian Cancer Registry [https://www.cancervic.org.au/research/vcr/cancer-fact-sheets/uterine-cancer.html]. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin DM, Whelan S, al. reWHO: International classification of diseases for oncology (IC...
Stage IIIC is the most common stage of locally advanced sub-stage of endometrial cancer, nevertheless, the optimal management for these patients remains controversial. Adjuvant chemotherapy alone more effectively suppressed distant metastases but resulted in a higher rate of pelvic failure, while adjuvant...
Prognostic indicators in stage III and localized stage IV breast cancer One hundred eighty-three patients with Stage III and nonmetastatic Stage IV breast cancer, seen between 1960鈥 1975 at the Division of Radiation Oncology, M... DV Rao,MD John Bedwinek,MD Carlos Perez,... - 《Cancer》 ...
It is estimated that in 2024, approximately 30% of all new female cancer diagnoses will be breast cancer. The 5-year relative survival rate for breast cancer diagnosed at the localized stage is 99%. Consequently, no country is an exception to the snowballing burden of BC. The cases of BC ...
A retrospective study was carried out on 202 eligible patients with stage III-B cancer of the uterine cervix admitted for radiotherapy from 1980-1997. Ninety-three patients were able to receive EBIC (50 Gy, 8 MV RX whole pelvis followed by one session of 38-45 Gy ICT to point A). The...
We then conducted the simulation under three alternative scenarios to estimate the contribution of racial differences in cancer incidence, stage at diagnosis and survival after diagnosis to racial differences in life expectancy. In scenario 1, to estimate the impact of incidence, we multiplied each ...
At this stage, the spread of cancer to the uterus and the tissues surrounding the uterus (called theparametrium) can trigger notable symptoms, such as:3 Abnormal uterine bleeding Heavier or longer periods Bleeding or spotting between periods ...
Cancer of the uterine cervix is one of the most common cancers among women worldwide and is particularly prevalent in developing nations.1 Platinum-based combination chemotherapy has been the standard first-line chemotherapy for recurrent or advanced cervical cancer.2 Currently, paclitaxel and cisplatin...
The effect on survival of radiographic lymph node metastasis in uterine cervical cancer patients is more important than before, even though its prognostic value not been well investigated. The aim of our study is to evaluate the prognostic potential of 18F-fluorodeoxyglucose Positron Emission Tomography...
The aim of this study was to determine the utility of DNA flow cytometry as a prognostic indicator for risk of recurrence and overall survival in patients with early stage adenocarcinomas of the uterine cervix. DNA flow cytometry was performed to determine ploidy, DNA index, and proliferative inde...